- Home
- MSAI vs COEP Comparison
MSAI vs COEP Comparison
Compare MSAI & COEP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MSAI
- COEP
- Stock Information
- Founded
- MSAI 1995
- COEP 2017
- Country
- MSAI United States
- COEP United States
- Employees
- MSAI N/A
- COEP N/A
- Industry
- MSAI
- COEP Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- MSAI
- COEP Health Care
- Exchange
- MSAI Nasdaq
- COEP Nasdaq
- Market Cap
- MSAI 23.6M
- COEP 27.4M
- IPO Year
- MSAI N/A
- COEP N/A
- Fundamental
- Price
- MSAI $0.86
- COEP $11.63
- Analyst Decision
- MSAI Strong Buy
- COEP
- Analyst Count
- MSAI 1
- COEP 0
- Target Price
- MSAI $2.50
- COEP N/A
- AVG Volume (30 Days)
- MSAI 148.8K
- COEP 52.7K
- Earning Date
- MSAI 08-13-2025
- COEP 08-15-2025
- Dividend Yield
- MSAI N/A
- COEP N/A
- EPS Growth
- MSAI N/A
- COEP N/A
- EPS
- MSAI N/A
- COEP N/A
- Revenue
- MSAI $6,297,000.00
- COEP $62,874.00
- Revenue This Year
- MSAI $66.87
- COEP N/A
- Revenue Next Year
- MSAI $81.01
- COEP N/A
- P/E Ratio
- MSAI N/A
- COEP N/A
- Revenue Growth
- MSAI N/A
- COEP N/A
- 52 Week Low
- MSAI $0.52
- COEP $2.31
- 52 Week High
- MSAI $3.33
- COEP $13.70
- Technical
- Relative Strength Index (RSI)
- MSAI 63.94
- COEP 66.85
- Support Level
- MSAI $0.71
- COEP $10.00
- Resistance Level
- MSAI $0.82
- COEP $11.70
- Average True Range (ATR)
- MSAI 0.08
- COEP 0.89
- MACD
- MSAI 0.01
- COEP 0.30
- Stochastic Oscillator
- MSAI 69.60
- COEP 76.97
About MSAI Infrared Cameras Holdings Inc.
MultiSensor AI Holdings Inc build and deploy intelligent multi-sensing platforms incorporating edge and cloud software solutions that leverage artificial intelligence (AI). It is a provider of sensing systems built around high-resolution thermal imagers, visible and acoustic imagers, as well as vibration and laser spectroscopy sensors, that perceive and measure heat, sound, vibration, and gas in industrial assets and the surrounding environment, helping companies gain insight to protect and manage their most important assets and infrastructure. It also offers a wide range of form factors for its sensor devices, including, among other form factors, small to large handheld designs with built-in displays and controls, and fixed-mounted single- and multi-sensor camera sensor systems.
About COEP Coeptis Therapeutics Holdings Inc.
Coeptis Therapeutics Holdings Inc is a biopharmaceutical company developing cell therapy platforms for patients with cancer. The company's product portfolio consists of multi-antigen CAR T technology licensed from the University of Pittsburgh (SNAP-CAR), a cell therapy technology (CD38-GEAR-NK), and an in vitro diagnostic (CD38-Diagnostic) targeting CD38-related cancers, which the company is developing with VyGen-Bio and medical researchers at the Karolinska Institutet.